Your browser doesn't support javascript.
loading
Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia.
Vorselaars, Veronique M M; Velthuis, Sebastiaan; Snijder, Repke J; Westermann, Cornelis J J; Vos, Jan A; Mager, Johannes J; Post, Martijn C.
Afiliação
  • Vorselaars VM; Dept of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands v.vorselaars@antoniusziekenhuis.nl.
  • Velthuis S; Dept of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands.
  • Snijder RJ; Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.
  • Westermann CJ; Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.
  • Vos JA; Dept of Interventional Radiology, St Antonius Hospital, Nieuwegein, The Netherlands.
  • Mager JJ; Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.
  • Post MC; Dept of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands.
Eur Respir J ; 47(6): 1750-7, 2016 06.
Article em En | MEDLINE | ID: mdl-26965291
ABSTRACT
Pulmonary arteriovenous malformations (PAVMs) are associated with severe neurological complications in hereditary haemorrhagic telangiectasia (HHT). Transthoracic contrast echocardiography (TTCE) is recommended for screening of pulmonary right-to-left shunts (RLS). Although growth of PAVMs is shown in two small studies, no studies on follow-up with TTCE exist.All HHT patients underwent a second TTCE 5 years after initial screening. Patients with a history of PAVM embolisation were excluded. Pulmonary RLS grade on TTCE after 5 years was compared to the grade at screening.200 patients (53.5% female, mean±sd age at screening 44.7±14.1 years) were included. Increase in RLS grade occurred in 36 (18%) patients, of whom six (17%) underwent embolisation. The change in grade between screening and follow-up was not more than one grade. Of patients with nontreatable pulmonary RLS at screening (n=113), 14 (12.4%) underwent embolisation. In patients without pulmonary RLS at initial screening (n=87), no treatable PAVMs developed during follow-up.Within 5 years, no treatable PAVMs developed in HHT patients without pulmonary RLS at initial screening. Increase in pulmonary RLS grade occurred in 18% of patients, and never increased by more than one grade. Of patients with nontreatable pulmonary RLS at initial screening, 12% underwent embolisation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artéria Pulmonar / Veias Pulmonares / Telangiectasia Hemorrágica Hereditária / Fístula Arteriovenosa / Pulmão Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artéria Pulmonar / Veias Pulmonares / Telangiectasia Hemorrágica Hereditária / Fístula Arteriovenosa / Pulmão Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda